Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

• Published in: Haemophilia : the official journal of the World Federation of Hemophilia Vol. 29; no. 1; pp. 404 - 407
• Main Authors: Sidonio, Robert F., Casiano, Sandra, Falk, Aletta, Altincatal, Arman, Katragadda, Suresh, Santagostino, Elena, Windyga, Jerzy
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.01.2023
• Subjects: clinical study; Coagulation factors; factor IX; Factor IX - pharmacokinetics; Factor IX - therapeutic use; factor IX Fc fusion protein; Fc receptors; Fusion protein; haemophilia B; Hemophilia B - drug therapy; Humans; Immunoglobulin Fc Fragments - therapeutic use; Pharmacokinetics; Recombinant Fusion Proteins - pharmacokinetics; Recombinant Fusion Proteins - therapeutic use; clinical study; pharmacokinetics; factor IX; haemophilia B; factor IX Fc fusion protein